Michael A Puskarich1, Jeffrey A Kline2, John A Watts3, Kristin Shirey4, Jonathan Hosler4, Alan E Jones5. 1. Department of Emergency Medicine, University of Mississippi Medical Center, Jackson, MS; Department of Biochemistry, University of Mississippi Medical Center, Jackson, MS. 2. Department of Emergency Medicine, University of Indiana School of Medicine, Indianapolis, IN. 3. Department of Emergency Medicine, Carolinas Medical Center, Charlotte, NC. 4. Department of Biochemistry, University of Mississippi Medical Center, Jackson, MS. 5. Department of Emergency Medicine, University of Mississippi Medical Center, Jackson, MS. Electronic address: aejones@umc.edu.
Abstract
INTRODUCTION: The objective of the study is to determine if changes in platelet mitochondrial function in patients with sepsis are present early after presentation and the association of these changes with clinical outcomes and systemic metabolic function. MATERIALS AND METHODS: This is a prospective observational cohort study of a convenience sample of patients with severe sepsis. Mitochondrial function of intact, nonpermeabilized platelets suspended in their own plasma was estimated using high-resolution respirometry. Unstimulated basal respiration, oligomycin-induced state 4, and maximal respiratory rate after serial titrations of carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone were measured. Organ failure was estimated using Sequential Organ Failure Assessment score, and patients were followed up until 28 days to determine survival. Lactate levels were measured in all patients, and a subset of patients had lactate/pyruvate (L/P) ratios measured. RESULTS: Twenty-eight patients were enrolled, 21 of whom survived. Initial Sequential Organ Failure Assessment score and lactate levels were 8.5 (interquartile range [IQR], 6-10) and 2.3 (IQR, 1.2-3.5) respectively, whereas the median L/P ratio was 23.4 (IQR, 15.2-38). Basal and maximal respiratory rates were significantly higher among nonsurvivors compared to survivors (P = .02 and P = .04), whereas oligomycin-induced state 4 respiration was not statistically different between groups (P = .15). We found a significant association between maximal respiration and organ failure (P = .03) and both basal and maximal rates with initial lactate level (P = .04, P = .02), but not with L/P ratio. CONCLUSIONS: Differences in platelet mitochondrial function between survivors and nonsurvivors are present very early in the hospital course and are associated with organ failure and lactate.
INTRODUCTION: The objective of the study is to determine if changes in platelet mitochondrial function in patients with sepsis are present early after presentation and the association of these changes with clinical outcomes and systemic metabolic function. MATERIALS AND METHODS: This is a prospective observational cohort study of a convenience sample of patients with severe sepsis. Mitochondrial function of intact, nonpermeabilized platelets suspended in their own plasma was estimated using high-resolution respirometry. Unstimulated basal respiration, oligomycin-induced state 4, and maximal respiratory rate after serial titrations of carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone were measured. Organ failure was estimated using Sequential Organ Failure Assessment score, and patients were followed up until 28 days to determine survival. Lactate levels were measured in all patients, and a subset of patients had lactate/pyruvate (L/P) ratios measured. RESULTS: Twenty-eight patients were enrolled, 21 of whom survived. Initial Sequential Organ Failure Assessment score and lactate levels were 8.5 (interquartile range [IQR], 6-10) and 2.3 (IQR, 1.2-3.5) respectively, whereas the median L/P ratio was 23.4 (IQR, 15.2-38). Basal and maximal respiratory rates were significantly higher among nonsurvivors compared to survivors (P = .02 and P = .04), whereas oligomycin-induced state 4 respiration was not statistically different between groups (P = .15). We found a significant association between maximal respiration and organ failure (P = .03) and both basal and maximal rates with initial lactate level (P = .04, P = .02), but not with L/P ratio. CONCLUSIONS: Differences in platelet mitochondrial function between survivors and nonsurvivors are present very early in the hospital course and are associated with organ failure and lactate.
Authors: E Rivers; B Nguyen; S Havstad; J Ressler; A Muzzin; B Knoblich; E Peterson; M Tomlanovich Journal: N Engl J Med Date: 2001-11-08 Impact factor: 91.245
Authors: Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay Journal: Crit Care Med Date: 2003-04 Impact factor: 7.598
Authors: Anna J Dare; Anthony R J Phillips; Anthony J R Hickey; Anubhav Mittal; Benjamin Loveday; Nichola Thompson; John A Windsor Journal: Free Radic Biol Med Date: 2009-08-26 Impact factor: 7.376
Authors: David Brealey; Michael Brand; Iain Hargreaves; Simon Heales; John Land; Ryszard Smolenski; Nathan A Davies; Chris E Cooper; Mervyn Singer Journal: Lancet Date: 2002-07-20 Impact factor: 79.321
Authors: David A Piel; Peter J Gruber; Carla J Weinheimer; Michael R Courtois; Charles M Robertson; Craig M Coopersmith; Clifford S Deutschman; Richard J Levy Journal: Crit Care Med Date: 2007-09 Impact factor: 7.598
Authors: H Bryant Nguyen; Emanuel P Rivers; Bernhard P Knoblich; Gordon Jacobsen; Alexandria Muzzin; Julie A Ressler; Michael C Tomlanovich Journal: Crit Care Med Date: 2004-08 Impact factor: 7.598
Authors: David H Jang; John C Greenwood; Shawn Owiredu; Abhay Ranganathan; David M Eckmann Journal: Mitochondrion Date: 2017-12-21 Impact factor: 4.160
Authors: David H Jang; Clinton J Orloski; Shawn Owiredu; Frances S Shofer; John C Greenwood; David M Eckmann Journal: Shock Date: 2019-05 Impact factor: 3.454
Authors: Bappaditya Ray; Vijay M Pandav; Eleanor A Mathews; David M Thompson; Lance Ford; Lori K Yearout; Bradley N Bohnstedt; Shuchi Chaudhary; George L Dale; Calin I Prodan Journal: Transl Stroke Res Date: 2017-12-09 Impact factor: 6.829
Authors: Marc R McCann; Cora E McHugh; Maggie Kirby; Theodore S Jennaro; Alan E Jones; Kathleen A Stringer; Michael A Puskarich Journal: Metabolites Date: 2020-04-02
Authors: Sebastien Preau; Dominique Vodovar; Boris Jung; Steve Lancel; Lara Zafrani; Aurelien Flatres; Mehdi Oualha; Guillaume Voiriot; Youenn Jouan; Jeremie Joffre; Fabrice Uhel; Nicolas De Prost; Stein Silva; Eric Azabou; Peter Radermacher Journal: Ann Intensive Care Date: 2021-07-03 Impact factor: 6.925
Authors: Wagner Luis Nedel; Afonso Kopczynski; Marcelo Salimen Rodolphi; Nathan Ryzewski Strogulski; Marco De Bastiani; Tiago Hermes Maeso Montes; Jose Abruzzi; Antonio Galina; Tamas L Horvath; Luis Valmor Portela Journal: Intensive Care Med Exp Date: 2021-07-24